News & Updates

Administering a single dose of psilocybin results in a significant reduction in depression scores over a period of 3 weeks but at the expense of increased adverse effects, according to the results of a phase II trial.

Treatment with haloperidol falls short of improving survival in intensive care unit (ICU) patients who are experiencing delirium, as shown in a study.

Early antiretroviral therapy (ART) in individuals with HIV offers better outcomes, particularly in those aged 35 years and younger, in a follow-up analysis of the START trial. Conversely, delayed therapy results in a higher risk of death and serious health issues in this population.

Pain control after a surgery may be tougher for cannabis users than for nonusers, with cannabis use being linked to higher postoperative pain scores and a trend toward greater use of opioids, as reported in a large study presented at the Anesthesiology 2022 Annual Meeting.

Patients who are refractory or intolerant to currently approved antifungal therapies exhibited a positive response to the novel triterpenoid antifungal ibrexafungerp, according to interim analysis results of the phase III FURI trial.

Use of atomoxetine and fesoterodine (Ato-Feso), administered for one night, helps manage obstructive sleep apnoea (OSA) in patients with milder upper airway collapsibility, although this treatment may not work in some individuals, a study has shown.